{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:54:34Z","timestamp":1793260474342,"version":"4.5.0"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.addr.2024.115219","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T06:02:55Z","timestamp":1708668175000},"page":"115219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Interactions between nanoparticles and pathological changes of vascular in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"207","author":[{"given":"Ting","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huile","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2024.115219_b0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2024.115219_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2024.115219_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.addr.2024.115219_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.addr.2024.115219_b0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2016.11.025","article-title":"Nanotechnology-based drug delivery systems for Alzheimer\u2019s disease management: technical, industrial, and clinical challenges","volume":"245","author":"Wen","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115219_b0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2024.115219_b0035","article-title":"Reversing cerebrovascular dysfunction","volume":"19","author":"Crunkhorn","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2024.115219_b0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/jcm8050651","article-title":"Vascular dysfunction in Alzheimer\u2019s disease: a prelude to the pathological process or a consequence of it?","volume":"6","author":"Govindpani","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.addr.2024.115219_b0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0197-4580(00)00102-0","article-title":"A damaged microcirculation contributes to neuronal cell death in Alzheimer\u2019s disease","volume":"21","author":"Grammas","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.addr.2024.115219_b0050","doi-asserted-by":"crossref","unstructured":"M.D. Sweeney, A. Montagne, A.P. Sagare, D.A. Nation, L.S. Schneider, H.C. Chui, M.G. Harrington, J. Pa, M. Law, D.J.J. Wang, R.E. Jacobs, F.N. Doubal, J. Ramirez, S.E. Black, M. Nedergaard, H. Benveniste, M. Dichgans, C. Iadecola, S. Love, P.M. Bath, H.S. Markus, R. Al\u2010Shahi Salman, S.M. Allan, T.J. Quinn, R.N. Kalaria, D.J. Werring, R.O. Carare, R.M. Touyz, S.C.R. Williams, M.A. Moskowitz, Z.S. Katusic, S.E. Lutz, O. Lazarov, R.D. Minshall, J. Rehman, T.P. Davis, C.L. Wellington, H.M. Gonz\u00e1lez, C. Yuan, S.N. Lockhart, T.M. Hughes, C.L.H. Chen, P. Sachdev, J.T. O'Brien, I. Skoog, L. Pantoni, D.R. Gustafson, G.J. Biessels, A. Wallin, E.E. Smith, V. Mok, A. Wong, P. Passmore, F. Barkof, M. Muller, M.M.B. Breteler, G.C. Rom\u00e1n, E. Hamel, S. Seshadri, R.F. Gottesman, M.A. van Buchem, Z. Arvanitakis, J.A. Schneider, L.R. Drewes, V. Hachinski, C.E. Finch, A.W. Toga, J.M. Wardlaw, B.V. Zlokovic, Vascular dysfunction\u2014The disregarded partner of Alzheimer's disease, Alzheimer's & Dementia, 15 (2019) 158-167.","DOI":"10.1016\/j.jalz.2018.07.222"},{"key":"10.1016\/j.addr.2024.115219_b0055","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3233\/CH-168047","article-title":"Vascular dysfunction-associated with Alzheimer\u2019s disease","volume":"64","author":"Carelli-Alinovi","year":"2017","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.addr.2024.115219_b0060","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/01.wnl.0000240129.46080.53","article-title":"Relationship of vascular risk to the progression of Alzheimer disease","volume":"67","author":"Regan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2024.115219_b0065","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.cclet.2021.01.014","article-title":"Nanomaterials toward the treatment of Alzheimer\u2019s disease: recent advances and future trends","volume":"32","author":"Zeng","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.addr.2024.115219_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114968","article-title":"siRNA drug delivery across the blood\u2013brain barrier in Alzheimer\u2019s disease","volume":"199","author":"Imran Sajid","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115219_b0075","article-title":"Natural polyphenolic nanodots for Alzheimer\u2019s disease treatment","author":"Yang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115219_b0080","first-page":"168","article-title":"Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases","volume":"23","author":"Huang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115219_b0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.aay2720","article-title":"The vascular side of Alzheimer\u2019s disease","volume":"365","author":"Liesz","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.addr.2024.115219_b0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.addr.2011.12.005","article-title":"Drug delivery to the brain in Alzheimer\u2019s disease: consideration of the blood-brain barrier","volume":"64","author":"Banks","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115219_b0095","article-title":"Microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of activated microglia","volume":"6","author":"Lu","year":"2018","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0100","article-title":"Multifunctional nanostructure RAP-RL rescues Alzheimer\u2019s cognitive deficits through remodeling the neurovascular unit","volume":"8","author":"Zhang","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0105","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","article-title":"Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer\u2019s disease","author":"Nelson","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2024.115219_b0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2022.12.003","article-title":"Vascular contributions to Alzheimer\u2019s disease","volume":"254","author":"Eisenmenger","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.addr.2024.115219_b0115","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2019.10.062","article-title":"Alzheimer's disease and vascular aging: JACC focus seminar","volume":"75","author":"Cortes-Canteli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2024.115219_b0120","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3233\/JAD-2012-111628","article-title":"Dynamic cerebral autoregulation in subjects with Alzheimer\u2019s disease, mild cognitive impairment, and controls: evidence for increased peripheral vascular resistance with possible predictive value","volume":"30","author":"Gommer","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2024.115219_b0125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00294173","article-title":"Pathological alterations of the cerebral microvasculature in Alzheimer\u2019s disease and related dementing disorders","volume":"87","author":"Buee","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.addr.2024.115219_b0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1749-6632.2000.tb06352.x","article-title":"Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer\u2019s disease, Parkinson\u2019s disease, and experimental hypertension. What is the functional link?","volume":"903","author":"Farkas","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-2010-100219","article-title":"A review of string vessels or collapsed, empty basement membrane tubes","volume":"21","author":"Brown","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2024.115219_b0140","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/BF00294246","article-title":"Altered angioarchitecture in selected areas of brains with Alzheimer\u2019s disease","volume":"79","author":"Fischer","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.addr.2024.115219_b0145","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00702-009-0226-9","article-title":"Evidence of angiogenic vessels in Alzheimer\u2019s disease","volume":"116","author":"Desai","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.addr.2024.115219_b0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00690372","article-title":"Morphometric comparison of hippocampal microvasculature in ageing and demented people: diameters and densities","volume":"53","author":"Bell","year":"1981","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.addr.2024.115219_b0155","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1710329115","article-title":"Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer\u2019s disease","volume":",115","author":"Bennett","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0160","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.jbiomech.2008.06.013","article-title":"Mechanical mechanisms of thrombosis in intact bent microvessels of rat mesentery","volume":"41","author":"Liu","year":"2008","journal-title":"J. Biomech."},{"key":"10.1016\/j.addr.2024.115219_b0165","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.90.22.10836","article-title":"Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease","volume":"90","author":"Roher","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0170","article-title":"Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer\u2019s disease. An immunoelectron microscopic study","volume":"141","author":"Yamaguchi","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2024.115219_b0175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams","year":"1995","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.addr.2024.115219_b0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2024.115219_b0185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2024.115219_b0190","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1474-4422(16)30029-1","article-title":"Relation of cerebral vessel disease to Alzheimer\u2019s disease dementia and cognitive function in elderly people: a cross-sectional study","author":"Arvanitakis","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.addr.2024.115219_b0195","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1093\/brain\/aws271","article-title":"Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias","volume":"135","author":"Yarchoan","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.addr.2024.115219_b0200","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1161\/01.STR.0000143317.70478.b3","article-title":"Atherosclerosis of cerebral arteries in Alzheimer disease","volume":"35","author":"Roher","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.addr.2024.115219_b0205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fnagi.2015.00115","article-title":"Impaired Abeta clearance: a potential link between atherosclerosis and Alzheimer\u2019s disease","volume":"7","author":"Gupta","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-019-0182-5","article-title":"Resolving atherosclerosis and Alzheimer disease","volume":"16","author":"Fredman","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.addr.2024.115219_b0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1568-1637(02)00064-8","article-title":"Microvascular plasticity in aging","volume":"2","author":"Riddle","year":"2003","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.addr.2024.115219_b0220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11357-017-9991-9","article-title":"Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer\u2019s disease","volume":"39","author":"Csiszar","year":"2017","journal-title":"GeroScience"},{"key":"10.1016\/j.addr.2024.115219_b0225","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.20493","article-title":"Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study","volume":"57","author":"Ruitenberg","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2024.115219_b0230","doi-asserted-by":"crossref","first-page":"7655","DOI":"10.1523\/JNEUROSCI.17-20-07655.1997","article-title":"Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein","volume":"17","author":"Zhang","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0235","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/380168a0","article-title":"beta-amyloid-mediated vasoactivity and vascular endothelial damage","volume":"380","author":"Thomas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115219_b0240","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/brain\/awx047","article-title":"Emerging concepts in sporadic cerebral amyloid angiopathy","volume":"140","author":"Charidimou","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.addr.2024.115219_b0245","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nn.4489","article-title":"Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain","volume":"20","author":"Kisler","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature13165","article-title":"Capillary pericytes regulate cerebral blood flow in health and disease","volume":"508","author":"Hall","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115219_b0255","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.addr.2024.115219_b0260","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0265","doi-asserted-by":"crossref","first-page":"18727","DOI":"10.1073\/pnas.0606298103","article-title":"Hypoxia facilitates Alzheimer\u2019s disease pathogenesis by up-regulating BACE1 gene expression","volume":"103","author":"Sun","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.addr.2024.115219_b0270","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1074\/jbc.M608856200","article-title":"Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation","volume":"282","author":"Zhang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2024.115219_b0275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JAD-130419","article-title":"Chronic intermittent hypoxia\/reoxygenation facilitate amyloid-beta generation in mice","volume":"37","author":"Shiota","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2024.115219_b0280","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s11064-007-9349-2","article-title":"Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes","volume":"32","author":"Fisk","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.addr.2024.115219_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002987","article-title":"Generative FDG-PET and MRI model of aging and disease progression in Alzheimer\u2019s disease","volume":"9","author":"Dukart","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.addr.2024.115219_b0290","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer\u2019s disease","volume":"132","author":"Liu","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.addr.2024.115219_b0295","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.354","article-title":"The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress","volume":"5","author":"van der Harg","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.addr.2024.115219_b0300","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.arcped.2013.12.015","article-title":"De vivo disease. GLUT-1 deficiency syndrome: a case report","volume":"21","author":"Daoudi","year":"2014","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.addr.2024.115219_b0305","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.cub.2016.07.017","article-title":"Increased glucose transport into neurons rescues Abeta toxicity in drosophila","volume":"26","author":"Niccoli","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.addr.2024.115219_b0310","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2967\/jnumed.116.187211","article-title":"Cerebrospinal fluid clearance in Alzheimer disease measured with dynamic PET","volume":"58","author":"de Leon","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2024.115219_b0315","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1212\/WNL.57.10.1763","article-title":"The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer\u2019s type","volume":"57","author":"Silverberg","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2024.115219_b0320","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jnc.13122","article-title":"Abeta(1\u201342) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins","volume":"134","author":"Wan","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2024.115219_b0325","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/awz011","article-title":"Selective loss of cortical endothelial tight junction proteins during Alzheimer\u2019s disease progression","volume":"142","author":"Yamazaki","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.addr.2024.115219_b0330","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/CIRCRESAHA.121.320183","article-title":"Endothelial BACE1 impairs cerebral small vessels via tight junctions and eNOS","volume":"130","author":"Zhou","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2024.115219_b0335","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2024.115219_b0340","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid beta-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2024.115219_b0345","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","article-title":"beta-amyloid efflux mediated by p-glycoprotein","volume":"76","author":"Lam","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2024.115219_b0350","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115219_b0355","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2024.115219_b0360","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.258","article-title":"Abeta1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-kappaB signaling","volume":"5","author":"Park","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.addr.2024.115219_b0365","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/00207454.2013.825258","article-title":"The potential mechanisms of Abeta-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer\u2019s disease","volume":"124","author":"Wan","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0370","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4155\/fmc.12.51","article-title":"Is RAGE still a therapeutic target for Alzheimer\u2019s disease?","volume":"4","author":"Deane","year":"2012","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.addr.2024.115219_b0375","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yexcr.2017.11.005","article-title":"Abeta(1\u201342) induces cell damage via RAGE-dependent endoplasmic reticulum stress in bEnd. 3 cells","volume":"362","author":"Chen","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.addr.2024.115219_b0380","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1471-4159.1989.tb07399.x","article-title":"Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease","volume":"53","author":"Kalaria","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2024.115219_b0385","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","article-title":"GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration","volume":"18","author":"Winkler","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0390","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"Mfsd2a is critical for the formation and function of the blood-brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115219_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010070","article-title":"Decreased blood level of MFSD2a as a potential biomarker of Alzheimer\u2019s disease","volume":"21","author":"Sanchez-Campillo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0400","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer\u2019s disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.addr.2024.115219_b0405","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3932","article-title":"Pericyte loss influences Alzheimer-like neurodegeneration in mice","volume":"4","author":"Sagare","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2024.115219_b0410","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1749-6632.2000.tb06368.x","article-title":"Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype","volume":"903","author":"Verbeek","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.addr.2024.115219_b0420","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.177.8.5574","article-title":"IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program","volume":"177","author":"Argaw","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2024.115219_b0425","article-title":"Interleukin-1beta induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115219_b0430","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0435","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1471-4914(03)00112-6","article-title":"Astrocytes: a cellular player in Abeta clearance and degradation","volume":"9","author":"Guenette","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.addr.2024.115219_b0440","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000438923","article-title":"The effect of Abeta(1)(-)(4)(2) oligomers on APP processing and Abeta(1)(-)(4)(0) generation in cultured U-373 astrocytes","volume":"15","author":"Ourdev","year":"2015","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.addr.2024.115219_b0445","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease","volume":"36","author":"Lian","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0450","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.13107","article-title":"Effects of ketone bodies in Alzheimer\u2019s disease in relation to neural hypometabolism, beta-amyloid toxicity, and astrocyte function","volume":"134","author":"Hertz","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2024.115219_b0455","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1093\/brain\/awab478","article-title":"APOE4 derived from astrocytes leads to blood-brain barrier impairment","volume":"145","author":"Jackson","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.addr.2024.115219_b0460","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.3913","article-title":"Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin","volume":"21","author":"Zenaro","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2024.115219_b0465","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0197-4580(01)00276-7","article-title":"Inflammatory factors are elevated in brain microvessels in Alzheimer\u2019s disease","volume":"22","author":"Grammas","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.addr.2024.115219_b0470","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-510X(91)90202-I","article-title":"Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer\u2019s disease","volume":"106","author":"Frohman","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0475","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0197-4580(96)00118-2","article-title":"Expression of CAP37, a novel inflammatory mediator, in Alzheimer\u2019s disease","volume":"17","author":"Anne Pereira","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.addr.2024.115219_b0480","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tice.2018.09.002","article-title":"Alterations in intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in human endothelial cells","volume":"54","author":"Habas","year":"2018","journal-title":"Tissue Cell"},{"key":"10.1016\/j.addr.2024.115219_b0485","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","article-title":"Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer\u2019s disease mouse models","volume":"22","author":"Cruz Hernandez","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0490","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48538-x","article-title":"Blockade of alpha4 integrins reduces leukocyte-endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Pietronigro","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2024.115219_b0495","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbd.2006.11.011","article-title":"Soluble adhesion molecules and angiotensin-converting enzyme in dementia","volume":"26","author":"Nielsen","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.addr.2024.115219_b0500","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3233\/JAD-150420","article-title":"Increased CSF E-selectin in clinical Alzheimer\u2019s disease without altered CSF Abeta42 and Tau","volume":"47","author":"Li","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2024.115219_b0505","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-2006-9105","article-title":"Thrombin and inflammatory proteins are elevated in Alzheimer\u2019s disease microvessels: implications for disease pathogenesis","volume":"9","author":"Grammas","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2024.115219_b0510","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JAD-2006-10114","article-title":"Angiogenic proteins are expressed by brain blood vessels in Alzheimer\u2019s disease","volume":"10","author":"Thirumangalakudi","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2024.115219_b0515","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2353\/ajpath.2010.090406","article-title":"Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer\u2019s disease","volume":"176","author":"Yin","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2024.115219_b0520","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jnr.1119","article-title":"Mechanisms of cell death in primary cortical neurons and PC12 cells","volume":"64","author":"Reimann-Philipp","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.addr.2024.115219_b0525","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.neurobiolaging.2003.07.007","article-title":"Thrombin, a mediator of neurotoxicity and memory impairment","volume":"25","author":"Mhatre","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.addr.2024.115219_b0530","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7692182","article-title":"Thrombin inhibition reduces the expression of brain inflammation markers upon systemic LPS treatment","volume":"2018","author":"Shavit Stein","year":"2018","journal-title":"Neural Plast."},{"key":"10.1016\/j.addr.2024.115219_b0535","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0304-3940(92)90065-F","article-title":"Thrombin accumulation in brains of patients with Alzheimer\u2019s disease","volume":"146","author":"Akiyama","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.addr.2024.115219_b0540","doi-asserted-by":"crossref","first-page":"37681","DOI":"10.1074\/jbc.M301406200","article-title":"Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling","volume":"278","author":"Suo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2024.115219_b0545","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2011.03.018","article-title":"Leukotriene D4 enhances tumor necrosis factor-alpha-induced vascular endothelial growth factor production in human monocytes\/macrophages","volume":"55","author":"Haneda","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.addr.2024.115219_b0550","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JAD-160477","article-title":"Severity-related increase and cognitive correlates of serum VEGF levels in Alzheimer\u2019s disease ApoE4 carriers","volume":"63","author":"Alvarez","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2024.115219_b0555","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fncel.2018.00215","article-title":"Microglia responses to pro-inflammatory stimuli (LPS, IFNgamma+TNFalpha) and reprogramming by resolving cytokines (IL-4, IL-10)","volume":"12","author":"Lively","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0560","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The role of astrocytes in CNS inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol."},{"issue":"Suppl. 3","key":"10.1016\/j.addr.2024.115219_b0565","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/00002093-199912003-00017","article-title":"Overlap between pathology of Alzheimer disease and vascular dementia","volume":"13","author":"Kalaria","year":"1999","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.addr.2024.115219_b0570","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007020200068","article-title":"Alzheimer disease and cerebrovascular pathology: an update","volume":"109","author":"Jellinger","year":"2002","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.addr.2024.115219_b0575","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1161\/STROKEAHA.108.533174","article-title":"Cerebral amyloid angiopathy: progressive disruption of the neurovascular unit","volume":"40","author":"Zipfel","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.addr.2024.115219_b0580","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0002-9440(10)64053-9","article-title":"Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy","volume":"158","author":"Christie","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2024.115219_b0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","article-title":"Cerebral amyloid angiopathy: a systematic review","volume":"7","author":"Biffi","year":"2011","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.addr.2024.115219_b0590","doi-asserted-by":"crossref","DOI":"10.1002\/alz.038899","article-title":"Amyloid angiopathy may contribute to white-matter hyperintensities in Alzheimer\u2019s disease","volume":"16","author":"Xia","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.addr.2024.115219_b0595","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.addr.2024.115219_b0600","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"Abeta-degrading enzymes in Alzheimer\u2019s disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.addr.2024.115219_b0605","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1750-3639.2006.tb00559.x","article-title":"The cerebral beta-amyloid angiopathies: hereditary and sporadic","volume":"16","author":"Zhang-Nunes","year":"2006","journal-title":"Brain Pathol."},{"key":"10.1016\/j.addr.2024.115219_b0610","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-009-0498-z","article-title":"Microvasculature changes and cerebral amyloid angiopathy in Alzheimer\u2019s disease and their potential impact on therapy","volume":"118","author":"Weller","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.addr.2024.115219_b0615","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jtbi.2005.07.005","article-title":"Mechanisms to explain the reverse perivascular transport of solutes out of the brain","volume":"238","author":"Schley","year":"2006","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.addr.2024.115219_b0620","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-011-0801-7","article-title":"Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy","volume":"121","author":"Hawkes","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.addr.2024.115219_b0625","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.22112","article-title":"Cerebral amyloid angiopathy pathology and cognitive domains in older persons","volume":"69","author":"Arvanitakis","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2024.115219_b0630","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ana.10810","article-title":"Clinical manifestations of cerebral amyloid angiopathy-related inflammation","volume":"55","author":"Eng","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2024.115219_b0635","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000260066.98681.2e","article-title":"Course of cerebral amyloid angiopathy-related inflammation","volume":"68","author":"Kinnecom","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2024.115219_b0640","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1474-4422(14)70003-1","article-title":"Outcome markers for clinical trials in cerebral amyloid angiopathy","volume":"13","author":"Greenberg","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.addr.2024.115219_b0645","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/brain\/awac178","article-title":"Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline","volume":"145","author":"Rabin","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.addr.2024.115219_b0650","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-2012-120757","article-title":"Arterial stiffness: detection and consequences in cognitive impairment and dementia of the elderly","volume":"32","author":"Rabkin","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2024.115219_b0655","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1161\/STROKEAHA.116.013508","article-title":"Aortic stiffness and the risk of incident mild cognitive impairment and dementia","volume":"47","author":"Pase","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.addr.2024.115219_b0660","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/jamaneurol.2014.186","article-title":"Arterial stiffness and beta-amyloid progression in nondemented elderly adults","volume":"71","author":"Hughes","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.addr.2024.115219_b0665","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCRESAHA.118.313563","article-title":"Getting to the heart of Alzheimer disease","volume":"124","author":"Tublin","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2024.115219_b0670","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"Abeta amyloid pathology affects the hearts of patients with Alzheimer\u2019s disease: mind the heart","volume":"68","author":"Troncone","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2024.115219_b0675","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/eurheartj\/ehad205","article-title":"Big tau aggregation disrupts microtubule tyrosination and causes myocardial diastolic dysfunction: from discovery to therapy","volume":"44","author":"Luciani","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.addr.2024.115219_b0680","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9343(84)90892-1","article-title":"Cerebral blood flow in patients with congestive heart failure treated with captopril","volume":"76","author":"Paulson","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.addr.2024.115219_b0685","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjmed.2012.05.029","article-title":"Cognitive impairment in older adults with heart failure: prevalence, documentation, and impact on outcomes","volume":"126","author":"Dodson","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.addr.2024.115219_b0690","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.1523\/JNEUROSCI.2350-05.2005","article-title":"Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer\u2019s disease pathogenesis","volume":"25","author":"Velliquette","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0695","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","article-title":"Progress and perspectives on targeting nanoparticles for brain drug delivery","volume":"6","author":"Gao","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2024.115219_b0700","first-page":"498","article-title":"Nanopreparations for mitochondria targeting drug delivery system: current strategies and future prospective","volume":"12","author":"Wang","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0705","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.apsb.2022.07.014","article-title":"Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2024.115219_b0710","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.2174\/138920112803341798","article-title":"The blood-brain\/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery","volume":"13","author":"Zhan","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.addr.2024.115219_b0715","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1021\/acsnano.3c09715","article-title":"Mannose-integrated nanoparticle hitchhike glucose transporter 1 recycling to overcome various barriers of oral delivery for Alzheimer\u2019s disease therapy","volume":"18","author":"Lei","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115219_b0720","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/1061186X.2021.1927055","article-title":"New advances in brain-targeting nano-drug delivery systems for Alzheimer\u2019s disease","volume":"30","author":"Ouyang","year":"2022","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2024.115219_b0725","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200129","article-title":"Modulating the blood\u2013brain tumor barrier for improving drug delivery efficiency and efficacy","volume":"3","author":"Song","year":"2022","journal-title":"View"},{"key":"10.1016\/j.addr.2024.115219_b0730","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1039\/C5BM00383K","article-title":"Strategies for transporting nanoparticles across the blood-brain barrier","volume":"4","author":"Zhang","year":"2016","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0735","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.colsurfb.2008.07.004","article-title":"Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size","volume":"66","author":"Sonavane","year":"2008","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.addr.2024.115219_b0740","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13052-018-0563-0","article-title":"Possible strategies to cross the blood-brain barrier","volume":"44","author":"Bellettato","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.addr.2024.115219_b0745","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biomaterials.2016.05.044","article-title":"Nanoscale effects in dendrimer-mediated targeting of neuroinflammation","volume":"101","author":"Nance","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115219_b0750","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/adhm.201400159","article-title":"Multimodal nanoprobes evaluating physiological pore size of brain vasculatures in ischemic stroke models","volume":"3","author":"Zheng","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2024.115219_b0755","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10555-020-09877-8","article-title":"Brain tumor vessels-a barrier for drug delivery","volume":"39","author":"Hempel","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.addr.2024.115219_b0760","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1479-5876-6-80","article-title":"Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells","volume":"6","author":"Sarin","year":"2008","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.addr.2024.115219_b0765","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2018.11.034","article-title":"ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson\u2019s and Huntington's diseases","volume":"1707","author":"Liu","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2024.115219_b0770","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2147\/IJN.S260375","article-title":"The influence of size and chemical composition of silver and gold nanoparticles on in vivo toxicity with potential applications to central nervous system diseases","volume":"16","author":"Baez","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2024.115219_b0775","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1021\/acs.nanolett.1c02996","article-title":"Reversibly modulating the blood-brain barrier by laser stimulation of molecular-targeted nanoparticles","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2024.115219_b0780","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-015-0133-1","article-title":"Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB)","volume":"13","author":"Sela","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2024.115219_b0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2019.107968","article-title":"Ultrasmall superparamagnetic iron oxide nanoparticles-bound NIR dyes: novel theranostic agents for Alzheimer\u2019s disease","volume":"173","author":"Cai","year":"2020","journal-title":"Dyes Pigm."},{"key":"10.1016\/j.addr.2024.115219_b0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.09774","article-title":"Ultra-small biomimetic nanoparticles for Alzheimer\u2019s disease targeted drug delivery","volume":"34","author":"Tatiparti","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2024.115219_b0795","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048515","article-title":"Intravenous delivery of targeted liposomes to amyloid-\u03b2 pathology in APP\/PSEN1 transgenic mice","volume":"7","author":"Tanifum","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115219_b0800","first-page":"1","article-title":"Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood\u2013brain barrier","author":"Wei","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2024.115219_b0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120888","article-title":"The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood\u2013brain barrier and attenuates their targeting ability to brain tumor","volume":"274","author":"Xiao","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115219_b0810","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/acs.molpharmaceut.6b01166","article-title":"Brain and organ uptake in the rhesus monkey in vivo of recombinant iduronidase compared to an insulin receptor antibody-iduronidase fusion protein","volume":"14","author":"Boado","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115219_b0815","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/anie.201411226","article-title":"A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery","volume":"54","author":"Wei","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2024.115219_b0820","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrd4522","article-title":"Transferrin' bispecific antibodies across the blood\u2013brain barrier","volume":"14","author":"Bray","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2024.115219_b0825","doi-asserted-by":"crossref","first-page":"20410","DOI":"10.1021\/acsami.7b03504","article-title":"In vitro study of receptor-mediated silica nanoparticles delivery across blood-brain barrier","volume":"9","author":"Song","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115219_b0830","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","article-title":"GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration","volume":"18","author":"Winkler","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b0835","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1021\/mp4002014","article-title":"Enhanced brain delivery of deferasirox-lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies","volume":"10","author":"Golnaz","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115219_b0840","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2016.01.031","article-title":"Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood\u2013brain barrier in vitro and in vivo","volume":"225","author":"Kafa","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115219_b0845","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.neuron.2017.02.043","article-title":"Gradual suppression of transcytosis governs functional blood-retinal barrier formation","volume":"93","author":"Chow","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.addr.2024.115219_b0850","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuron.2017.03.043","article-title":"Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis","volume":"94","author":"Andreone","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.addr.2024.115219_b0855","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biomaterials.2015.09.041","article-title":"Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery","volume":"74","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115219_b0860","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biomaterials.2016.04.021","article-title":"Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy","volume":"97","author":"Fang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115219_b0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(02)00670-X","article-title":"Connective tissue growth factor in Alzheimer\u2019s disease","volume":"116","author":"Ueberham","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.addr.2024.115219_b0870","first-page":"592","article-title":"Binding studies of truncated variants of the A\u03b2 peptide to the V-domain of the RAGE receptor reveal A\u03b2 residues responsible for binding","volume":"2011","author":"Gospodarska","year":"1814","journal-title":"BBA - Proteins and Proteomics"},{"key":"10.1016\/j.addr.2024.115219_b0875","article-title":"Nano-brake halts mitochondrial dysfunction cascade to alleviate neuropathology and rescue Alzheimer\u2019s cognitive deficits","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115219_b0880","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.apsb.2022.02.001","article-title":"Intelligent lesion blood\u2013brain barrier targeting nano-missiles for Alzheimer\u2019s disease treatment by anti-neuroinflammation and neuroprotection","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2024.115219_b0885","article-title":"Pathological BBB crossing melanin-like nanoparticles as metal-ion chelators and neuroinflammation regulators against Alzheimer\u2019s disease","volume":"6","author":"Huang","year":"2023","journal-title":"Research (Washington, DC)"},{"key":"10.1016\/j.addr.2024.115219_b0890","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.apsb.2021.04.022","article-title":"A nanocleaner specifically penetrates the bloodbrain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer\u2019s disease","volume":"11","author":"Lei","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2024.115219_b0895","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1021\/acsnano.0c02733","article-title":"A biocompatible second near-infrared nanozyme for spatiotemporal and non-invasive attenuation of amyloid deposition through scalp and skull","volume":"14","author":"Ma","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115219_b0900","article-title":"Biomimetic dendrimer-peptide conjugates for early multi-target therapy of Alzheimer\u2019s disease by inflammatory microenvironment modulation","volume":"33","author":"Liu","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115219_b0905","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202206959","article-title":"Peptide-functionalized prussian blue nanomaterial for antioxidant stress and NIR photothermal therapy against Alzheimer\u2019s disease","volume":"19","author":"Song","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.addr.2024.115219_b0910","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/acsami.2c18060","article-title":"Stepwise coordination-driven metal-phenolic nanoparticle as a neuroprotection enhancer for Alzheimer\u2019s disease therapy","volume":"15","author":"Yin","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115219_b0915","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1021\/acsami.1c17861","article-title":"Gold nanorods with spatial separation of CeO(2) deposition for plasmonic-enhanced antioxidant stress and photothermal therapy of Alzheimer\u2019s disease","volume":"14","author":"Ge","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115219_b0920","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1021\/acsami.2c19839","article-title":"Imine-linked covalent organic framework modulates oxidative stress in Alzheimer\u2019s disease","volume":"15","author":"Ren","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115219_b0925","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4155\/fmc-2019-0329","article-title":"Radiolabeling of [(11)C]FPS-ZM1, a receptor for advanced glycation end products-targeting positron emission tomography radiotracer, using a [(11)C]CO(2)-to-[(11)C]CO chemical conversion","volume":"12","author":"Luzi","year":"2020","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.addr.2024.115219_b0930","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1038\/s41467-019-12554-2","article-title":"Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2024.115219_b0935","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01096-0","article-title":"Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer\u2019s disease","volume":"8","author":"Mann","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2024.115219_b0940","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101748","article-title":"\u201cCascaded rocket\u201d nanosystems with spatiotemporal separation for triple-synergistic therapy of Alzheimer\u2019s disease","volume":"11","author":"Liu","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2024.115219_b0945","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/glia.20973","article-title":"The role and therapeutic potential of monocytic cells in Alzheimer\u2019s disease","volume":"58","author":"Malm","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.addr.2024.115219_b0950","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","article-title":"Occurrence of T cells in the brain of Alzheimer\u2019s disease and other neurological diseases","volume":"124","author":"Togo","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.addr.2024.115219_b0955","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2023.06.023","article-title":"Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: insights and challenges","volume":"360","author":"Wu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115219_b0960","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.actbio.2020.03.029","article-title":"Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer\u2019s disease mice","volume":"108","author":"Gao","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115219_b0965","first-page":"337","article-title":"Engineered macrophage-biomimetic versatile nanoantidotes for inflammation-targeted therapy against Alzheimer\u2019s disease by neurotoxin neutralization and immune recognition suppression","volume":"26","author":"Cheng","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.addr.2024.115219_b0970","article-title":"Biomimetic liposomes hybrid with platelet membranes for targeted therapy of atherosclerosis","volume":"408","author":"Song","year":"2020","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.addr.2024.115219_b0975","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202100701","article-title":"A noninvasive gut-to-brain oral drug delivery system for treating brain tumors","volume":"33","author":"Miao","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115219_b0980","article-title":"Ligustrazine nanoparticle hitchhiking on neutrophils for enhanced therapy of cerebral ischemia-reperfusion injury","volume":"10","author":"Mu","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.addr.2024.115219_b0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.142955","article-title":"Engineered urinary-derived extracellular vesicles loaded nanoenzymes as Trojan horses to regulate the inflammatory microenvironment for treatment of Alzheimer\u2019s disease","volume":"465","author":"Bai","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.addr.2024.115219_b0990","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301779","article-title":"Bacteria-derived outer-membrane vesicles hitchhike neutrophils to enhance ischemic stroke therapy","volume":"35","author":"Pan","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115219_b0995","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biomaterials.2017.07.023","article-title":"Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer\u2019s disease by concurrently inducing neurogenesis and reducing apoptosis in APP\/PS1 transgenic mice","volume":"145","author":"Guo","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115219_b1000","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301361","article-title":"Study on the role of an erythrocyte membrane-coated nanotheranostic system in targeted immune regulation of Alzheimer\u2019s disease","volume":"10","author":"Su","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115219_b1005","first-page":"529","article-title":"Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer\u2019s disease mice","volume":"6","author":"Han","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.addr.2024.115219_b1010","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.jcis.2023.07.132","article-title":"Macrophage membrane-encapsulated nitrogen-doped carbon quantum dot nanosystem for targeted treatment of Alzheimer\u2019s disease: regulating metal ion homeostasis and photothermal removal of \u03b2-amyloid","volume":"650","author":"Ye","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2024.115219_b1015","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1021\/acsnano.2c12840","article-title":"Multiscale NIR-II imaging-guided brain-targeted drug delivery using engineered cell membrane nanoformulation for Alzheimer\u2019s disease therapy","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115219_b1020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04591.x","article-title":"In vivo targeting of antibody fragments to the nervous system for Alzheimer\u2019s disease immunotherapy and molecular imaging of amyloid plaques","volume":"102","author":"Poduslo","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2024.115219_b1025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/NEN.0b013e318225038c","article-title":"Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid beta protein antibody-coated nanoparticles","volume":"70","author":"Poduslo","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.addr.2024.115219_b1030","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1007\/s11095-008-9688-y","article-title":"Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer\u2019s disease and cerebral amyloid angiopathy","volume":"25","author":"Agyare","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2024.115219_b1035","first-page":"250","article-title":"Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer\u2019s disease amyloid protein, nanomedicine: nanotechnology","volume":"8","author":"Jaruszewski","year":"2012","journal-title":"Biol. Med."},{"key":"10.1016\/j.addr.2024.115219_b1040","first-page":"258","article-title":"Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer\u2019s disease brain, nanomedicine: nanotechnology","volume":"16","author":"Ahlschwede","year":"2019","journal-title":"Biol. Med."},{"key":"10.1016\/j.addr.2024.115219_b1045","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.biomaterials.2013.10.075","article-title":"Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer\u2019s disease brain","volume":"35","author":"Jaruszewski","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115219_b1050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mcn.2009.11.004","article-title":"HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin","volume":"43","author":"Ie","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2010.05.1408","article-title":"P2\u2013356: Guiding anti-RAGE monoclonal antibody development for the treatment of Alzheimer\u2019s disease via imaging","volume":"6","author":"Luo","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.addr.2024.115219_b1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108304","article-title":"RP1, a RAGE antagonist peptide, can improve memory impairment and reduce a\u03b2 plaque load in the APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"180","author":"Huang","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.addr.2024.115219_b1065","first-page":"40","article-title":"Regulatory effects of simvastatin and apoJ on APP processing and amyloid-beta clearance in blood-brain barrier endothelial cells","volume":"2018","author":"Zandl-Lang","year":"1863","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.addr.2024.115219_b1070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2019.04.031","article-title":"LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases","volume":"303","author":"Guo","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115219_b1075","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-40736-x","article-title":"Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus","volume":"9","author":"Seok","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2024.115219_b1080","doi-asserted-by":"crossref","DOI":"10.3389\/conf.fncel.2016.36.00151","article-title":"Neuroprotective effects of thymoquinone-rich fraction nanoemulsion in hypercholesterolemia-induced rat model of sporadic Alzheimer\u2019s disease","volume":"10","author":"Norsharina","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b1085","first-page":"H693","article-title":"Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer\u2019s disease and vascular cognitive impairment","volume":"314","author":"Van","year":"2017","journal-title":"Am. J. Physiol. Heart Circul. Physiol."},{"key":"10.1016\/j.addr.2024.115219_b1090","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","article-title":"Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer\u2019s disease","volume":"33","author":"Lin","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.addr.2024.115219_b1095","doi-asserted-by":"crossref","first-page":"4616-","DOI":"10.3390\/ijms20184616","article-title":"Norvaline restores the BBB integrity in a mouse model of Alzheimer\u2019s disease","volume":"20","author":"Polis","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2024.115219_b1100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12974-016-0692-6","article-title":"The anti-inflammatory annexin A1 induces the clearance and degradation of the amyloid-\u03b2 peptide","volume":"13","author":"Ries","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.addr.2024.115219_b1105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106201","article-title":"Vitamin B12 as a cholinergic system modulator and blood brain barrier integrity restorer in Alzheimer\u2019s disease","volume":"174","author":"El-Mezayen","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2024.115219_b1110","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4103\/1673-5374.239445","article-title":"Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1\u201342","volume":"13","author":"Chen-Yang","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.addr.2024.115219_b1115","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1177\/0271678X19873658","article-title":"Increasing cerebral blood flow improves cognition into late stages in Alzheimer\u2019s disease mice","volume":"40","author":"Bracko","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.addr.2024.115219_b1120","article-title":"Retraction: ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology","volume":"21","author":"Raja","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.addr.2024.115219_b1125","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s11357-023-00786-6","article-title":"Rapamycin restores peripheral blood flow in aged mice and in mouse models of atherosclerosis and Alzheimer\u2019s disease","volume":"45","author":"Van Skike","year":"2023","journal-title":"GeroScience"},{"key":"10.1016\/j.addr.2024.115219_b1130","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/awab387","article-title":"VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer\u2019s mice","volume":"145","author":"Ali","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.addr.2024.115219_b1135","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207238","article-title":"Brain-penetrating and disease site-targeting manganese dioxide-polymer-lipid hybrid nanoparticles remodel microenvironment of Alzheimer\u2019s disease by regulating multiple pathological pathways","volume":"10","author":"Park","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115219_b1140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b1145","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.3233\/JAD-200730","article-title":"CDK5 targeting as a therapy for recovering neurovascular unit integrity in Alzheimer\u2019s disease","volume":"82","author":"Posada-Duque","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.addr.2024.115219_b1150","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.772278","article-title":"Carbonic anhydrases as potential targets against neurovascular unit dysfunction in Alzheimer\u2019s disease and stroke","volume":"13","author":"Lemon","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b1155","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-170474","article-title":"GDF11 rejuvenates cerebrovascular structure and function in an animal model of Alzheimer\u2019s disease","volume":"62","author":"Zhang","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.addr.2024.115219_b1160","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1177\/0271678X16658489","article-title":"Losartan improves cerebrovascular function in a mouse model of Alzheimer\u2019s disease with combined overproduction of amyloid-\u03b2 and transforming growth factor-\u03b21","volume":"37","author":"Papadopoulos","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.addr.2024.115219_b1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113112","article-title":"Neural stem cell therapy for neurovascular injury in Alzheimer\u2019s disease","volume":"324","author":"Boese","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.addr.2024.115219_b1170","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2337\/db18-595-P","article-title":"Statins decrease VEGF expression in retinal pigment epithelial cells by downregulation of receptor for AGE (RAGE)","volume":"67","author":"Tsujinaka","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2024.115219_b1175","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2024.115219_b1180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","article-title":"The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature","volume":"106","author":"Yan","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2024.115219_b1185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00253-015-7001-7","article-title":"A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid beta peptide-mediated neuronal disorder","volume":"100","author":"Cai","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.addr.2024.115219_b1190","first-page":"338","article-title":"The effect of valsartan on the expression of the receptor for advanced glycation end products in human glomerular mesangial cells","volume":"27","author":"Zhong","year":"2011","journal-title":"Chin. J. Appl. Physiol."},{"key":"10.1016\/j.addr.2024.115219_b1195","article-title":"Resveratrol inhibits high glucose-induced H9c2 cardiomyocyte hypertrophy and damage via RAGE-dependent inhibition of the NF","volume":"2022","author":"Zhu","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.addr.2024.115219_b1200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/JME-12-0119","article-title":"Upregulation of hepatic LRP1 by rosiglitazone: a possible novel mechanism of the beneficial effect of thiazolidinediones on atherogenic dyslipidemia","volume":"49","author":"Moon","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.addr.2024.115219_b1205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030816","article-title":"Anthocyanin-rich extract from red chinese cabbage alleviates vascular inflammation in endothelial cells and apo E(-\/-) mice","volume":"19","author":"Joo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2024.115219_b1210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-017-0917-x","article-title":"Regulation of human brain microvascular endothelial cell adhesion and barrier functions by memantine","volume":"62","author":"Wang","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.addr.2024.115219_b1215","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/0960327120960775","article-title":"Sildenafil ameliorates Alzheimer disease via the modulation of vascular endothelial growth factor and vascular cell adhesion molecule-1 in rats","volume":"40","author":"Ibrahim","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.addr.2024.115219_b1220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nnano.2014.17","article-title":"Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils","volume":"9","author":"Wang","year":"2014","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2024.115219_b1225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCRESAHA.119.315185","article-title":"Rapamycin-loaded biomimetic nanoparticles reverse vascular inflammation","volume":"126","author":"Boada","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2024.115219_b1230","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004025","article-title":"Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release","volume":"8","author":"Ruan","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115219_b1235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038149","article-title":"Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models","volume":"7","author":"Urich","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115219_b1240","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909999","article-title":"Endo\/Lysosome-escapable delivery depot for improving BBB transcytosis and neuron targeted therapy of Alzheimer\u2019s disease","volume":"30","author":"Cai","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2024.115219_b1245","first-page":"5171","article-title":"Recent advances in nanotechnology for combating Alzheimer\u2019s disease, materials chemistry","volume":"7","author":"Hu","year":"2023","journal-title":"Frontiers"},{"key":"10.1016\/j.addr.2024.115219_b1250","doi-asserted-by":"crossref","DOI":"10.34133\/2022\/9847612","article-title":"Glymphatic system and subsidiary pathways drive nanoparticles away from the brain","volume":"2022","author":"Liu","year":"2022","journal-title":"Research"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:49:13Z","timestamp":1759211353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X24000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":250,"alternative-id":["S0169409X24000413"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2024.115219","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between nanoparticles and pathological changes of vascular in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2024.115219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115219"}}